The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Donald Trump said talks with North Korea on the summit were going “very well”.
Organisers issued a warning about a “dangerous high strength or bad batch substance on site”.
Anna Campbell was the first British woman to die fighting with Kurdish forces in the war-torn country.